Pamela Shrader
Family Medicine · Princeton, WVNPI 1932942646
Payments from drug & device makers
Across 152 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$402
- Amgen$271
- Kowa Pharmaceuticals America, Inc.$247
- Novo Nordisk$229
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$204
- Boehringer Ingelheim$202
- plus $832 from 12 others
What the payments were for
- Food & beverage$2,386100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $402 |
| Amgen | 22 | $271 |
| Kowa Pharmaceuticals America, Inc. | 22 | $247 |
| Novo Nordisk | 13 | $229 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $204 |
| Boehringer Ingelheim | 12 | $202 |
| AbbVie | 15 | $185 |
| Lilly USA, LLC | 9 | $181 |
| Exact Sciences | 4 | $80 |
| GSK | 5 | $79 |
| Esperion Therapeutics, Inc. | 3 | $70 |
| Shield Therapeutics Inc | 2 | $47 |
| Pfizer | 3 | $46 |
| Dexcom, Inc. | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Biomerieux Inc | 1 | $21 |
| Insulet Corporation | 1 | $15 |
How this compares
$2,386 in reported general payments places this provider in the 80th percentile of 843 family medicine providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 43 | $52,151 |
| OzempicSemaglutide | 12 | $25,691 |
| FarxigaDapagliflozin Propanediol | 17 | $25,082 |
| VascepaIcosapent Ethyl | 11 | $11,384 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,162 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $957 |
| Rosuvastatin Calcium | 53 | $916 |
| Omeprazole | 30 | $453 |
| Fluticasone Propionate | 17 | $423 |
| Cefdinir | 23 | $417 |
| Levothyroxine Sodium | 37 | $406 |
| Losartan Potassium | 32 | $406 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $402 |
| Famotidine | 27 | $372 |
| Gabapentin | 33 | $354 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $202 | $52,15143 claims |
| Novo NordiskOzempic | $229 | $25,69112 claims |
| AstraZenecaFarxiga | $402 | $25,08217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Princeton
- Ryan RunyonPrinceton$21K
- Phillip PetersonPrinceton$7K
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Julie DetempleSouth Charleston$129K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
- Mark CucuzzellaHarpers Ferry$59K
- Courtney PilkertonMorgantown$45K
- Isha WoofterClarksburg$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.